U. Peitz

发表

S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF

J. Bornschein, P. Malfertheiner, S. Suerbaum, 2009, Zeitschrift fur Gastroenterologie.

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.

A. Blum, M. Stolte, E. Verdu, 1996, Gastroenterology.

Long-term consequences of Helicobacter pylori eradication: clinical aspects.

J. Labenz, U. Peitz, B. Tillenburg, 1996, Scandinavian journal of gastroenterology. Supplement.

Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients.

A. Blum, M. Stolte, J. Labenz, 1997, The American journal of gastroenterology.

[Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].

P. Malfertheiner, U. Peitz, 2007, Zeitschrift fur Gastroenterologie.

Missing gastric cancer in dyspepsia

P. Malfertheiner, H. Lippert, U. Peitz, 2005, Alimentary pharmacology & therapeutics.

A novel immunoassay based on monoclonal antibodies for the detection of Helicobacter pylori antigens in human stool

P. Malfertheiner, A. Leodolter, U. Peitz, 2001, Zeitschrift fur Gastroenterologie.

Role of aging in the expression of Helicobacter pylori gastritis in the antrum, corpus, and cardia.

P. Malfertheiner, U. Peitz, A. Hackelsberger, 1999, Scandinavian journal of gastroenterology.

Diagnostic Accuracy of 13C-Urea Breath Test in the Diagnosis of Helicobacter pylori Infection in Patients with Partial Gastric Resection due to Peptic Ulcer Disease

M. Stolte, R. Jakobs, D. Schilling, 2001, Digestion.

[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori].

M. Stolte, J. Labenz, U. Peitz, 1995, Leber, Magen, Darm.

Carditis at the Interface between GERD and Helicobacter pylori Infection

P. Malfertheiner, M. Vieth, U. Peitz, 2004, Digestive Diseases.

The Magnified Endoscopic View of Cardia-Type Mucosa

A. Roessner, S. Kahl, P. Malfertheiner, 2004, Zeitschrift fur Gastroenterologie.

S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit” der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS)

P. Malfertheiner, S. Suerbaum, U. Rosien, 2009, Zeitschrift fur Gastroenterologie.

[Helicobacter pylori infection--an update for 2004].

P. Malfertheiner, U. Peitz, G. Treiber, 2004, Deutsche medizinische Wochenschrift.

Diagnostics of Helicobacter pylori infection in patients with peptic ulcer bleeding.

P. Malfertheiner, T. Welte, A. Leodolter, 2004, Zeitschrift fur Gastroenterologie.

[Insufficient validity of a rapid blood test for diagnosis of Helicobacter pylori infection].

P. Malfertheiner, M. Stolte, J. Labenz, 2001, Medizinische Klinik.

What Parameters Are Relevant for the Histological Diagnosis of Gastroesophageal Reflux Disease without Barrett’s Mucosa?

P. Malfertheiner, S. Willich, M. Vieth, 2004, Digestive Diseases.

Cathepsins K, L, B, X and W are differentially expressed in normal and chronically inflamed gastric mucosa

P. Malfertheiner, A. Roessner, E. Weber, 2004, Biological chemistry.

Helicobacter pylori Genotypes and Expression of Gastritis in Erosive Gastro-oesophageal Reflux Disease

P. Malfertheiner, A. Leodolter, M. Ebert, 2003, Scandinavian journal of gastroenterology.

Helicobacter pylori eradication and gastric ulcer healing — comparison of three pantoprazole‐based triple therapies

P. Malfertheiner, A. Leodolter, T. Kirchner, 2003, Alimentary pharmacology & therapeutics.

Cure of Helicobacter pylori-associated ulcer disease through eradication.

P. Malfertheiner, A. Leodolter, U. Peitz, 2000, Bailliere's best practice & research. Clinical gastroenterology.

One‐week low‐dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers

J. Labenz, U. Peitz, B. Tillenburg, 1997, Alimentary pharmacology & therapeutics.

Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)

A. Kandulski, L. Macke, Albert Lukas Philip Severin Ulrike Karl Matthias Matthias Beyer Bossaller Bufler Daum Denzer Dichtl , 2024, Zeitschrift für Gastroenterologie.

Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.

A. Blum, M. Stolte, J. Labenz, 1997, Gut.

Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O 104 : H 4 in the Netherlands

M. Bielaszewska, S. Rehmet, A. Magiorakos, 2011 .

High rate of post‐therapeutic resistance after failure of macrolide–nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second‐line therapies in a randomized study

P. Malfertheiner, M. Stolte, A. Leodolter, 2002, Alimentary pharmacology & therapeutics.